To collect evidence that supports this idea, we considered our previous findings that the Alox5 gene plays an essential role in functional regulation of LSCs for both PV and CML [15,16], two different types of myeloproliferative neoplasms driven by JAK2V617F and BCR-ABL, respectively. This evidence concerns the gene ALOX5 and myeloproliferative neoplasm.